Fusion Pharmaceuticals' GAAP loss for 6M 2021 was $44.82 million, down 18.4% from $54.955 million in the previous year. Revenue was $521,000. A year earlier, the company not generated revenue.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept